Home World News Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally... World News Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 235 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR TG4001 Therapeutic Vaccination Plus Avelumab-Mediated PD-L1 Blockade Improves Tumour Microenvironment in... December 12, 2020 Ponatinib Effectively Treats Newly Diagnosed Acute Lymphoblastic Leukemia: The ASCO Plenary... February 14, 2023 Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:... January 18, 2022 Does Too Much Fructose Help Colorectal Cancers Grow? October 29, 2021 Load more HOT NEWS EMA Recommends Extension of Indications for Crizotinib Withdrawal of the Application to Change the EMA Marketing Authorisation for... Trastuzumab Emtansine Improves OS with Sustained Improvement in iDFS Among Patients... Feeding the Gut
